1887

Abstract

Human immunodeficiency virus type 1 (HIV-1) splicing has to be strictly controlled to ensure the balanced production of the unspliced and all differently spliced viral RNAs. Splicing at the major 5′ splice site (5′ss) that is used for the synthesis of all spliced RNAs is modulated by the local RNA structure and binding of regulatory SR proteins. Here, we demonstrate that the suboptimal sequence complementarity between this 5′ss and U1 small nuclear RNA (snRNA) also contributes to prevent excessive splicing. Analysis of a large set of HIV-1 sequences revealed that all three regulatory features of the 5′ss region (RNA structure, SR protein binding and sequence complementarity with U1 snRNA) are highly conserved amongst virus isolates, which supports their importance. Combined mutations that destabilize the local RNA structure, remove binding sites for inhibitory SR proteins and optimize the U1 snRNA complementarity resulted in almost complete splicing and accordingly reduced virus replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000288
2015-11-01
2024-12-09
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/11/3389.html?itemId=/content/journal/jgv/10.1099/jgv.0.000288&mimeType=html&fmt=ahah

References

  1. Abbink T.E., Berkhout B. 2008; RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor. J Virol 82:3090–3098 [View Article][PubMed]
    [Google Scholar]
  2. Asang C., Erkelenz S., Schaal H. 2012; The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence. Virology 432:133–145 [View Article][PubMed]
    [Google Scholar]
  3. Cartegni L., Wang J., Zhu Z., Zhang M.Q., Krainer A.R. 2003; ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568–3571 [View Article][PubMed]
    [Google Scholar]
  4. Das A.T., Verhoef K., Berkhout B. 2004a; A conditionally replicating virus as a novel approach toward an HIV vaccine. Methods Enzymol 388:359–379 [View Article][PubMed]
    [Google Scholar]
  5. Das A.T., Zhou X., Vink M., Klaver B., Verhoef K., Marzio G., Berkhout B. 2004b; Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem 279:18776–18782 [View Article][PubMed]
    [Google Scholar]
  6. Freund M., Asang C., Kammler S., Konermann C., Krummheuer J., Hipp M., Meyer I., Gierling W., Theiss S., other authors. 2003; A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res 31:6963–6975 [View Article][PubMed]
    [Google Scholar]
  7. Mueller N., van Bel N., Berkhout B., Das A.T. 2014; HIV-1 splicing at the major splice donor site is restricted by RNA structure. Virology 468–470:609–620 [View Article][PubMed]
    [Google Scholar]
  8. Mueller N., Berkhout B., Das A.T. 2015; HIV-1 splicing is controlled by local RNA structure and binding of splicing regulatory proteins at the major 5′ splice site. J Gen Virol 96:1906–1917 [View Article][PubMed]
    [Google Scholar]
  9. Roca X., Krainer A.R., Eperon I.C. 2013; Pick one, but be quick: 5′ splice sites and the problems of too many choices. Genes Dev 27:129–144 [View Article][PubMed]
    [Google Scholar]
  10. Smith P.J., Zhang C., Wang J., Chew S.L., Zhang M.Q., Krainer A.R. 2006; An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15:2490–2508 [View Article][PubMed]
    [Google Scholar]
  11. Zuker M. 2003; Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415 [View Article][PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.000288
Loading
/content/journal/jgv/10.1099/jgv.0.000288
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error